# TAP Using Dexmedetomidine and Ropivacaine for Cesarean Section Analgesia

> **NCT05700045** · NA · COMPLETED · sponsor: **Xijing Hospital** · enrollment: 90 (actual)

## Conditions studied

- Multimodal Analgesia
- Cesarean Section

## Interventions

- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT05700045
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-31
- **Primary completion:** 2023-09-28
- **Final completion:** 2023-09-30
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2023-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05700045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05700045, "TAP Using Dexmedetomidine and Ropivacaine for Cesarean Section Analgesia". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT05700045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*